Breaking News Instant updates and real-time market news.

AVGO

Broadcom

$277.40

-7.22 (-2.54%)

, QCOM

Qualcomm

$68.38

0.24 (0.35%)

07:46
11/29/17
11/29
07:46
11/29/17
07:46

Broadcom could offer $100 for Qualcomm in accretive deal, says Canaccord

Canaccord analyst T. Michael Walkley raised his estimates on Broadcom (AVGO) ahead of its Q4 results. The analyst anticipates an increased offer for Qualcomm (QCOM) and said a deal would still be accretive at $100 per share. The combination would make Broadcom the third largest semiconductor company in the world and would position it for strong long-term earnings and cash flow generation, said, Walkley, who reiterated his Buy rating and raised his price target to $313 from $300 on Broadcom shares.

AVGO

Broadcom

$277.40

-7.22 (-2.54%)

QCOM

Qualcomm

$68.38

0.24 (0.35%)

  • 06

    Dec

  • 06

    Mar

AVGO Broadcom
$277.40

-7.22 (-2.54%)

11/29/17
11/29/17
DOWNGRADE
Target $75

Hold
Qualcomm downgraded to Hold after Broadcom bid at Stifel
As previously reported, Stifel analyst Kevin Cassidy downgraded Qualcomm (QCOM) to Hold from Buy, arguing that the risk in the shares is now greater than the potential reward following the company's recent rejection of Broadcom's (AVGO) $70 per share bid. If Broadcom withdraws the offer, Qualcomm shares may return to the $47-$55 range, while if an acquisition deal is struck the price could be a mix of cash and stock in the high-$70 to $80 range, Cassidy believes. He raised his price target on Qualcomm to $75 from $65 based on the potential for an increased offer, which he expects.
11/27/17
BMOC
11/27/17
NO CHANGE
Target $25
BMOC
Market Perform
Marvell price target raised to $25 from $16 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Marvell (MRVL) to $25 in the wake of its Cavium (CAVM) acquisition, saying the deal makes sense since the combined entity will have greater earnings power as smaller companies find it increasingly more challenging to compete. Srivastava says that while there is some overlap between the two entities, there are enough businesses that complement each other, allowing for better positioning relative to Broadcom (AVGO). The analyst keeps his Market Perform rating on Marvell.
11/20/17
OPCO
11/20/17
NO CHANGE
Target $30
OPCO
Outperform
Marvell price target raised to $30 from $23 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Marvell (MRVL) to $30 from $23 after the company announced plans to acquire Cavium (CAVM) in a 50/50 cash/stock transaction valuing the latter at about $84/share. The analyst believes that acquiring Cavium increases Marvell's exposure to the datacenter/networking markets, creating a robust portfolio to better compete against powerhouse Broadcom (AVGO). Schafer sees the deal as a strategic use of Marvell's $1.6B in cash, and says he is bullish on the combination. He reiterates an Outperform rating on Marvell's shares.
11/20/17
BMOC
11/20/17
NO CHANGE
Target $330
BMOC
Outperform
Broadcom resumed at BMO Capital with Outperform
BMO Capital analyst Ambrish Srivastava resumed coverage of Broadcom (AVGO) with an Outperform rating and a price target of $330, up from $200 when previously covered. Srivastava says the company continues to translate its acquisitions into "meaningful" earnings and free cash flow accretion. The analyst adds that he is positive on Brodcom's "audacious" bid for Qualcomm (QCOM), noting that shares could be valued at $410-$450 if the proposed acquisition goes through, leading to combined-company free cash flows doubling to about $20B.
QCOM Qualcomm
$68.38

0.24 (0.35%)

11/28/17
STFL
11/28/17
DOWNGRADE
STFL
Hold
Qualcomm downgraded to Hold from Buy at Stifel
11/14/17
RBCM
11/14/17
NO CHANGE
Target $77
RBCM
Outperform
Qualcomm price target raised to $77 from $70 at RBC Capital
RBC Capital analyst Amit Daryanani raised his price target on Qualcomm (QCOM) to $77 after yesterday's formal rejection of $70 per share offer from Broadcom (AVGO). Daryanani says the rejection is not a surprise, noting that the next likely steps are for Broadcom to present its offer to shareholders and escalate the process to a proxy battle that may yield a higher bid. The analyst keeps his Outperform rating on Qualcomm, saying investors will likely agree to the Broadcom deal at a higher price of "high $70's to low $80's".

TODAY'S FREE FLY STORIES

ADBE

Adobe

$175.00

-1.83 (-1.03%)

07:15
12/15/17
12/15
07:15
12/15/17
07:15
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIGL

Rigel Pharmaceuticals

$3.57

-0.15 (-4.03%)

07:14
12/15/17
12/15
07:14
12/15/17
07:14
Initiation
Rigel Pharmaceuticals initiated  »

Cantor sees FDA approval…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

CRTO

Criteo

$24.42

-7.19 (-22.75%)

07:12
12/15/17
12/15
07:12
12/15/17
07:12
Downgrade
Criteo rating change  »

Criteo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$50.19

0.14 (0.28%)

07:11
12/15/17
12/15
07:11
12/15/17
07:11
Recommendations
Oracle analyst commentary  »

Oracle business momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIPR

Innovative Industrial Properties

$22.60

2.28 (11.22%)

07:10
12/15/17
12/15
07:10
12/15/17
07:10
Hot Stocks
Innovative Industrial Properties raises quarterly dividend to 25c per share »

Innovative Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOLX

Hologic

$42.96

-0.72 (-1.65%)

07:08
12/15/17
12/15
07:08
12/15/17
07:08
Recommendations
Hologic analyst commentary  »

Hologic positioned well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFGC

Performance Food Group

$30.55

-0.9 (-2.86%)

07:07
12/15/17
12/15
07:07
12/15/17
07:07
Earnings
Performance Food Group sees FY18 adjusted EPS up 13%-18% »

For fiscal 2018, PFG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

TYME

Tyme Technologies

$3.30

0.05 (1.54%)

07:05
12/15/17
12/15
07:05
12/15/17
07:05
Initiation
Tyme Technologies initiated  »

Tyme Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

, SNY

Sanofi

$43.09

-0.83 (-1.89%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Hot Stocks
Alnylam announces lift of FDA clinical hold on Fitusiran »

Alnylam Pharmaceuticals…

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

SNY

Sanofi

$43.09

-0.83 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

  • 02

    May

UA

Under Armour; also tag UAA

$12.45

0.09 (0.73%)

, UAA

Under Armour; also tag UA

$13.82

0.2 (1.47%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Upgrade
Under Armour; also tag UAA, Under Armour; also tag UA rating change  »

Under Armour upgraded to…

UA

Under Armour; also tag UAA

$12.45

0.09 (0.73%)

UAA

Under Armour; also tag UA

$13.82

0.2 (1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBA

Ritchie Bros.

$28.69

0.3 (1.06%)

07:04
12/15/17
12/15
07:04
12/15/17
07:04
Hot Stocks
Ritchie Bros. sess $50M+ of equipment in final Fort Worth, TX auction of 2017 »

This week Ritchie Bros.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$43.09

-0.83 (-1.89%)

, ALNY

Alnylam

$123.66

-1.2 (-0.96%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
Sanofi says FDA lifts clinical hold on fitusiran »

Sanofi Genzyme, the…

SNY

Sanofi

$43.09

-0.83 (-1.89%)

ALNY

Alnylam

$123.66

-1.2 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 25

    Mar

  • 02

    May

CROX

Crocs

$10.94

-0.34 (-3.01%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Upgrade
Crocs rating change  »

Crocs upgraded to Buy on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 08

    Jan

ESNC

EnSync

$0.44

0.0663 (17.79%)

, CHTR

Charter

$328.68

-0.32 (-0.10%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
EnSync: Spectrum solar plus storage project commissioned in Hawaii »

EnSync (ESNC) announces…

ESNC

EnSync

$0.44

0.0663 (17.79%)

CHTR

Charter

$328.68

-0.32 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

PFGC

Performance Food Group

$30.55

-0.9 (-2.86%)

07:03
12/15/17
12/15
07:03
12/15/17
07:03
Hot Stocks
Performance Food Group appoints Jim Hope as CFO »

Performance Food Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

ACRS

Aclaris Therapeutics

$24.72

-0.38 (-1.51%)

07:02
12/15/17
12/15
07:02
12/15/17
07:02
Hot Stocks
Aclaris Therapeutics receives FDA approval for Eskata topical solution, 40% »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

AER

AerCap

$52.12

-0.46 (-0.87%)

07:01
12/15/17
12/15
07:01
12/15/17
07:01
Recommendations
AerCap analyst commentary  »

AerCap book value can hit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTWO

Q2 Holdings

$37.30

-0.75 (-1.97%)

07:00
12/15/17
12/15
07:00
12/15/17
07:00
Recommendations
Q2 Holdings analyst commentary  »

Q2 Holdings has strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

07:00
12/15/17
12/15
07:00
12/15/17
07:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.82

-0.2 (-2.85%)

06:59
12/15/17
12/15
06:59
12/15/17
06:59
Downgrade
Fitbit rating change  »

Fitbit downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,174.80

10.61 (0.91%)

06:55
12/15/17
12/15
06:55
12/15/17
06:55
Periodicals
Luxembourg appeals EU order to recover tax from Amazon, Reuters reports »

Luxembourg is appealing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ACRS

Aclaris Therapeutics

$24.72

-0.38 (-1.51%)

06:55
12/15/17
12/15
06:55
12/15/17
06:55
Hot Stocks
Breaking Hot Stocks news story on Aclaris Therapeutics »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

GDX

Market Vector Gold Miners

$22.07

-0.09 (-0.41%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$110.57

2.96 (2.75%)

, FOXA

21st Century Fox

$34.88

2.13 (6.50%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Recommendations
Disney, 21st Century Fox analyst commentary  »

Disney price target…

DIS

Disney

$110.57

2.96 (2.75%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

GLD

SPDR Gold Trust

$118.93

-0.24 (-0.20%)

06:54
12/15/17
12/15
06:54
12/15/17
06:54
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.